Jupiter Life Line Hospitals (MAINBOARD)
Sep 6, 2023 - Sep 8, 2023
| Price | ₹695 - ₹735 |
| Premium | ₹246 |
|---|---|
| Lot size | 20 |
| Allotment | Sep 13, 2023 |
| Listing | Sep 18, 2023 |
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| Retail | 1 | 20 | 14700 | 206923 |
| sHNI | 14 | 280 | 205800 | 2111 |
| bHNI | 69 | 1380 | 1014300 | 4223 |
Last Updated as on 08-Sep-2023 17:54:00
| Category | Offered | Applied | Times |
|---|---|---|---|
| QIBs | 23,72,880 | 44,44,94,800 | 187.32 |
| HNIs | 18,37,287 | 6,38,46,320 | 34.75 |
| HNIs (10+L) | 12,24,858 | 4,80,57,860 | 39.24 |
| HNIs (2-10L) | 6,12,429 | 1,57,88,460 | 25.78 |
| Retail | 42,87,002 | 3,31,18,980 | 7.73 |
| Total | 84,97,169 | 54,14,60,100 | 63.72 |
Incorporated in 2007, Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India.
Jupiter Life Line Hospitals has been operating as a corporate quaternary care healthcare service provider in the western regions of India and currently operates three hospitals under the "Jupiter" brand in Thane, Pune, and Indore, with a total operational bed capacity of 1194 beds, and 1,306 doctors including specialists, physicians, and surgeons, as of March 31, 2023. The company is currently developing a multi-specialty hospital in Dombivli, Maharashtra, which is designed to accommodate over 500 beds and has commenced construction in April 2023.
According to the CRISIL Report, the company's Thane and Indore hospitals are amongst the few hospitals in the western region of India to provide neuro-rehabilitation services through a dedicated robotic and computer-assisted neuro-rehabilitation center. Additionally, it operates one of the few multi-organ transplant centers in Thane. All the hospitals in Thane, Pune, and Indore have been certified by the National Accreditation Board for Hospitals & Healthcare Providers (NABH) and have been accredited in the field of medical testing by the National Accreditation Board for Testing and Calibration Laboratories (NABL).
The company's inpatient and outpatient revenue is diversified across hospitals with Thane, Pune, and Indore hospitals accounting for 54.18%, 34.03%, and 11.79%, respectively, of the revenue from operations in Fiscal 2023.
Jupiter Life Line Hospitals IPO Details
Jupiter Life Line Hospitals IPO is a Book Built Issue. The IPO total issue size is Rs [.]. The Jupiter Life Line Hospitals IPO price is [.] to [.] per share. The IPO will list on BSE, NSE.
| Issue Size | |
| Fresh Issue | [.] shares (aggregating up to ₹542.00 Cr) |
| Offer for Sale | 4,450,000 shares of ₹10 (aggregating up to ₹[.] Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Share holding pre issue | 58,191,859 |
Jupiter Life Line Hospitals IPO Reservation
| QIB Shares Offered | Not more than 50.00% of the Net offer |
| NII (HNI) Shares Offered | Not less than 15.00% of the Offer |
| Retail Shares Offered | Not less than 35.00% of the Offer |
Company Financials
| Period | Mar 2021 | Mar 2022 | Mar 2023 |
| Assets | 788.91 | 908.70 | 985.53 |
| Revenue | 490.27 | 737.14 | 902.96 |
| Profit | -2.30 | 51.13 | 72.91 |
| Net Worth | 246.44 | 288.43 | 363.91 |
| Reserves | |||
| Borrowing | 425.52 | 495.25 | 468.63 |
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: jupiterlife.ipo@kfintech.com
Website: https://kosmic.kfintech.com/ipostatus/